Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study of Palonosetron in the Prophylaxis/Rescue of Radiation Induced Nausea and Vomiting (RINV) - a Phase II Study

NCT02388750 is registered in ClinicalTrials.gov with Dr. Edward Chow as lead sponsor.

NCT NCT02388750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02388750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study of Palonosetron in the Prophylaxis/Rescue of Radiation Induced Nausea and Vomiting (RINV) - a Phase II Study
Lead sponsor
Dr. Edward Chow
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2015
Completion date
August 7, 2017
Enrollment
96 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nausea, vomiting